← Back to Search

Other

Curcumin Pill for Subdural Hematoma (CACTIS Trial)

Phase < 1
Waitlist Available
Led By Howard Yonas, MD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

CACTIS Trial Summary

Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas Recurrence

Eligible Conditions
  • Subdural Hematoma

CACTIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measurements by CT of subdural hematoma volume change
Secondary outcome measures
Recurrence rate of cSDH with and without CC treatment
Other outcome measures
Patient's neurological status

CACTIS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Curcumin pills groupExperimental Treatment1 Intervention
24 Patient will receive Curcumin (CC) pills, within 24 hours post-operatively (as long as they are able to take oral medication). It will then be continued TID
Group II: Placebo groupPlacebo Group1 Intervention
24 Patient will receive Placebo pills, within 24 hours post-operatively (as long as they are able to take oral medication. It will then be continued TID.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Curcumin Pill
2015
N/A
~80

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
372 Previous Clinical Trials
3,528,789 Total Patients Enrolled
Howard Yonas, MDPrincipal InvestigatorUNM

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
The AAPS JournalJournal
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, Subash C., Sridevi Patchva, and Bharat B. Aggarwal. 2012. “Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials”. The AAPS Journal. Springer Science and Business Media LLC. doi:10.1208/s12248-012-9432-8.
clinicaltrials.govStudy
Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas Recurrence
2018. "Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas Recurrence". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03845322.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top